The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Exhibit Hall Presentation: An Overview of Clinical Data for ENHERTU® (fam-trastuzumab deruxtecan-nxki) in 2L HER2+ Metastatic Breast Cancer <br> Daiichi-Sankyo</br>